Placeholder Banner

BIO Applauds Passage of Federal Approach to GMO Disclosure

July 14, 2016

Washington, D.C. (July 14, 2016) – The Biotechnology Innovation Organization (BIO) welcomes Congressional passage of a federal, uniform approach to GMO disclosure. 

“The Congress’ strong, bipartisan support for a national GMO labeling and disclosure solution is a win for consumers, farmers, businesses, and agricultural innovation,” said Jim Greenwood, BIO’s President and CEO.

“More than one thousand stakeholder organizations came together in support of this agreement and we commend the many leaders in the U.S. Congress for making this issue a top priority,” added Greenwood.  “We are pleased that President Obama has said he will sign this important bill.”

Discover More
WASHINGTON, D.C. – Phyllis Arthur, Executive Vice President and Head of Health Policy and Programs of the Biotechnology Innovation Organization (BIO) released the following statement on the December 2025 ACIP meeting.“For decades, the CDC’s Advisory…
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO) released the following statement on reports of the retirement of Richard Pazdur from the US FDA.“Dr. Pazdur has dedicated decades of his career…
WASHINGTON, D.C. – The Biotechnology Innovation Organization (BIO) released the following statement on today’s passage of the Mikaela Naylon Give Kids a Chance Act in the House of Representatives.“The unanimous House passage of the Mikaela Naylon…